Genisphere LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Genisphere LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013355
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genisphere LLC (Genisphere) is a nanotechnology company which provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapuetics. It develops pipeline products in areas of oncology and ocular. Genisphere offers GL 249, is a preventative treatment of Posterior Capsule Opacification (PCO), a vision impairing disease that occurs in some adults and in most children following cataract surgery. It also develops GL 233 which regulates the expression of multiple genes known to function in tumor cell survival and in drug resistance. Genisphere is headquartered in Hatfield, Pennsylvania, the US.

Genisphere LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genisphere LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Genisphere LLC, Medical Devices Deals, 2011 to YTD 2017 9
Genisphere LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Genisphere LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Genisphere Raises USD2 Million in Venture Financing 11
Partnerships 12
Genisphere Enters into Agreement with Inserm 12
Genisphere Enters into Research Agreement with University of Maryland 13
MedImmune Enters into Agreement with Genisphere 14
Genisphere Enters into Research Agreement with University of Pennsylvania 15
MultiCell Technologies Enters Into Agreement With Genisphere To Develop MCT-485 16
Genisphere Enters Into Agreement With Lankenau Institute for Medical Research To Develop Nanotherapeutics 17
Licensing Agreements 18
Genisphere Receives License from LIMR Development 18
Equity Offering 19
Genisphere Raises USD4 Million in Private Placement of Shares 19
Genisphere LLC – Key Competitors 20
Genisphere LLC – Key Employees 21
Genisphere LLC – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Government and Public Interest 23
Nov 15, 2017: Genisphere Reports Safety of 3DNA Nanocarrier 23
Product News 24
03/08/2016: Innovative Approach to Ovarian Cancer Treatment Unveiled by Biomedical Scientists at the Lankenau Institute for Medical Research 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Genisphere LLC, Pharmaceuticals & Healthcare, Key Facts 2
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genisphere LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genisphere LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genisphere LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Genisphere LLC, Medical Devices Deals, 2011 to YTD 2017 9
Genisphere LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Genisphere Raises USD2 Million in Venture Financing 11
Genisphere Enters into Agreement with Inserm 12
Genisphere Enters into Research Agreement with University of Maryland 13
MedImmune Enters into Agreement with Genisphere 14
Genisphere Enters into Research Agreement with University of Pennsylvania 15
MultiCell Technologies Enters Into Agreement With Genisphere To Develop MCT-485 16
Genisphere Enters Into Agreement With Lankenau Institute for Medical Research To Develop Nanotherapeutics 17
Genisphere Receives License from LIMR Development 18
Genisphere Raises USD4 Million in Private Placement of Shares 19
Genisphere LLC, Key Competitors 20
Genisphere LLC, Key Employees 21

★海外企業調査レポート[Genisphere LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Breckenridge Pharmaceutical Inc:企業のM&A・事業提携・投資動向
    Breckenridge Pharmaceutical Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Breckenridge Pharmaceutical Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Finance Wales plc:企業のM&A・事業提携・投資動向
    Finance Wales plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finance Wales plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Cogentix Medical Inc (CGNT):医療機器:M&Aディール及び事業提携情報
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc is a medical device company that offers patient care products. The company offers products such as macroplastique, PrimeSight, urgent pc and ptq products, among others. Its products are used in critical care, faecal incont …
  • Reliance Worldwide Corporation Ltd (RWC):企業の財務・戦略的SWOT分析
    Reliance Worldwide Corporation Ltd (RWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Devon Energy Corporation:企業の戦略・SWOT・財務情報
    Devon Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Devon Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ramky Infrastructure Limited:企業の戦略・SWOT・財務情報
    Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report Summary Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Landis+Gyr AG-エネルギー分野:企業M&A・提携分析
    Summary Landis+Gyr AG (Landis+Gyr) is an integrated energy management company that provide end-to-end advanced metering solutions. It delivers comprehensive services including cloud services, managed services, smart grid services, software services, solutions consulting and support services. The com …
  • Bank of Taiwan:企業の戦略・SWOT・財務分析
    Bank of Taiwan - Strategy, SWOT and Corporate Finance Report Summary Bank of Taiwan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Fabric Development Inc:企業の戦略的SWOT分析
    Fabric Development Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • McCarthy Building Companies Inc:企業の戦略的SWOT分析
    McCarthy Building Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Chaman Lal Setia Exports Ltd:企業の戦略・SWOT・財務分析
    Chaman Lal Setia Exports Ltd - Strategy, SWOT and Corporate Finance Report Summary Chaman Lal Setia Exports Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • BYD Company Limited:企業の戦略・SWOT・財務分析
    BYD Company Limited - Strategy, SWOT and Corporate Finance Report Summary BYD Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TUI Group:企業の戦略・SWOT・財務分析
    TUI Group - Strategy, SWOT and Corporate Finance Report Summary TUI Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Agile Therapeutics Inc (AGRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • AstraZeneca KK-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca KK (AstraZeneca), a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic dis …
  • Paladin Energy Ltd (PDN):企業の財務・戦略的SWOT分析
    Paladin Energy Ltd (PDN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • JFE Holdings Inc (5411):企業の財務・戦略的SWOT分析
    JFE Holdings Inc (5411) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • i-Optics BV:医療機器:M&Aディール及び事業提携情報
    Summary I-Optics BV (I-Optics) is a medical device company that manufactures and distributes optical devices. The company offers Cassini, a corneal shape analyzer that measures the axis and magnitude of corneal astigmatism and EasyScan, a zero-dilation retinal imaging system to diagnose retinal dise …
  • Platinum Group Metals Ltd (PTM):企業の財務・戦略的SWOT分析
    Platinum Group Metals Ltd (PTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Hutchison China Meditech Ltd
    Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report Summary Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆